Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation

NCT07447297 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07447297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07447297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
January 2, 2024
Completion date
December 31, 2029
Enrollment
520 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), atrial flutter, diseases of the circulatory system